News

Institute for Precision Medicine Receives $2.8 Million Grant from the RK Mellon Foundation

The Institute for Precision Medicine (IPM) at the University of Pittsburgh and UPMC received a three-year $2.8 million grant from the Richard King Mellon Foundation for implementation of precision medicine initiatives, including whole genome sequencing of critically ill infants, genomics education and translational research pilot projects intended for commercialization.

The IPM, a joint effort of Pitt and UPMC,

News

IPM supported research demonstrates clinical impact

A genetic test developed by researchers at the University of Pittsburgh School of Medicine and the Pittsburgh Liver Research Center and partially supported by the 2016 IPM Pilot Program in precision medicine has been published this week in the journal Gut. The test known as ‘Biliseq’ assesses bile duct cacners for actionable genetic markers.

News

New publication from the IPM and Pitt Molecular Biology Information Service

Biomedical researchers are increasingly reliant on obtaining bioinformatics training in order to conduct their research. We recently published a paper discussing how at Pitt we have been making resources available through our Molecular Biology Information Service (MBIS) of the Health Sciences Library System. The MBIS runs a four-facet service with the following goals:

(1) identify, procure and implement commercially licensed bioinformatics software

(2) teach hands-on workshops using bioinformatics tools to solve research questions

(3) provide in-person and email consultations on software/databases

(4) maintain a web portal providing overall guidance on the access and use of bioinformatics resources and MBIS-created webtools.

News

IPM announces pilot award recipients

We had a fantastic response to our two Pilot Programs in Precision Medicine which we announced in December 2018. These pilots support the use of two key University of Pittsburgh/UPMC resources which are vital components in precision medicine research, the Pitt Biospecimen Core (PBC) and the new UPMC Genome Center (UGC).

Congratulations to the investigators and their project teams selected to receive funding through this competitive process.

Uncategorized News

Dr Empey to moderate a session at the Precision Medicine World Leaders Summit 2019

The Institue for Precision Medicine Associate Director of Pharmacogenomics, Philip Empey, PharmD, PhD, will be moderating a session at the Precision Medicine World Leaders Summit East at UPenn School of Medicine, Philadelphia, June 11-12, 2019.

Dr Empey will moderate a discussion on the role of Pharmacogenomics in precision medicine which will take place at 11.20am on June 11th.

News

IPM announce pilot awards to support the use of Pitt Biospecimen Core

The Institute for Precision Medicine (IPM)

Announce Pilot Project Funding in

Support of Human Tissue Requests from the Pitt Biospecimen Core (PBC)

The Institute for Precision Medicine (IPM; www.ipm.pitt.edu) is a collaboration between the University of Pittsburgh and UPMC. The IPM facilitates the movement of precision medicine research into personalized clinical care.

News

New IPM pilot projects announced in support of whole genome sequencing

The Institute for Precision Medicine (IPM)

Announce Pilot Project Funding in

Support of Next Generation Sequencing at the UPMC Genome Center (UGC)

The Institute for Precision Medicine (IPM; www.ipm.pitt.edu) is a collaboration between the University of Pittsburgh and UPMC. The IPM facilitates the movement of precision medicine research into personalized clinical care.

News

IPM featured at the ASHG conference

The Institue for Precision Medicine and our ongoing work at UPMC and the University of Pittsburgh was featured on ‘AHSG TV’ at the 2018 American Society of Human Genetics conference held in San Diego, California. October 16-20th.

To see the short film produced for this please click here.

News

​UPMC and Pitt Launch Genome Center to Advance Precision Medicine and Immunotherapy

UPMC and the University of Pittsburgh today announced the launch of an advanced genome sequencing center to support clinical diagnostics and research initiatives in precision medicine and immunotherapy.

The UPMC Genome Center, established with funding from the recently announced UPMC Immune Transplant and Therapy Center(ITTC) and the Institute for Precision Medicine at UPMC and Pitt,

News

IPM Associate Director to Lead New Pharmacogenomics Center of Excellence

The University of Pittsburgh and Thermo Fisher Scientific have established a new Pharmacogenomics Center of Excellence in the School of Pharmacy that aims to discover and validate medication response predictors in patients, overcome implementation barriers, and demonstrate the value of genetic testing to guide medication prescribing in routine clinical practice. Pharmacogenomics is the study of how genetic variation impacts medication responses.

News